What They Do
Elevance Health (formerly Anthem) is one of the largest health benefits companies in the United States, providing health insurance plans to approximately 47 million members across 14 states. The company operates as a managed care organization, collecting premiums from individuals, employers, and government programs while managing healthcare costs and provider networks to generate profits from the spread.
Investment Thesis
**Scale advantage** — As the second-largest health insurer by membership, ELV leverages significant negotiating power with healthcare providers and pharmaceutical companies**Diversified revenue streams** — Revenue comes from commercial employer plans (~40%), government programs like Medicaid (~35%), and Medicare Advantage (~25%), reducing dependence on any single segment**Geographic expansion opportunity** — Strong presence in high-growth states and potential for market share gains in existing markets through competitive biddingKey Risks
**Regulatory pressure** — Increasing government scrutiny of health insurer practices, medical loss ratio requirements, and potential healthcare reform could compress margins**Medical cost inflation** — Rising healthcare costs, physician shortages, and post-pandemic utilization normalization could pressure profitability if premium increases lag expense growthGrowth Story
ELV has demonstrated consistent mid-single-digit revenue growth driven by membership expansion in government programs, particularly Medicaid and Medicare Advantage. The company is well-positioned to benefit from an aging U.S. population driving Medicare enrollment and state Medicaid expansion programs. Recent contract wins and renewals support continued membership growth trajectory.
Profitability Profile
The company maintains healthy operating margins typically in the 4-6% range, with profitability driven by effectively managing medical loss ratios (target of 85-87% for most segments). ELV generates strong free cash flow conversion, enabling consistent dividend payments and share repurchases while maintaining solid balance sheet strength for growth investments.
Competitive Position
ELV competes with UnitedHealth Group, Aetna (CVS), and regional players in a consolidated market where scale matters significantly. The company's competitive moat stems from its provider network relationships, data analytics capabilities, and operational scale that enables competitive pricing while maintaining margins.
Recent Momentum
Without access to recent earnings data, the company has historically faced headwinds from elevated medical costs as healthcare utilization normalized post-COVID. The market has been closely watching medical loss ratio trends and management's ability to appropriately price for medical inflation in renewal cycles.
What Wall Street Thinks
Analysts typically focus on ELV's ability to manage medical cost trends, membership growth in government programs, and margin stability. The stock often trades on medical loss ratio guidance and execution, with particular attention to Medicaid redetermination impacts and Medicare Advantage rate adequacy.
The Bottom Line
ELV is a large, profitable health insurer whose success hinges on its ability to accurately price for medical costs while growing membership in an aging demographic environment—a fundamental challenge that separates winners from losers in managed care.
